About Christopher Benoit
Christopher Benoit is a co-ceo and director at Canal Biosciences.
Form D filings also name Christopher Benoit as a chief executive officer and director at TwinStrand Biosciences.
Christopher Benoit first appears on SEC filings in 2018.
Experience
This experience comes from Christopher Benoit's profile and from SEC filings. For roles taken from filings, the years are when the filings name Christopher Benoit in the role, so the role may have started earlier or lasted longer.
Canal Biosciences, Inc. Current
Co-Chief Executive Officer (2024 – Present)
Director
2024 – Present · Lowell, MA
DNA preparation kits for researchers who sequence DNA.
BL
Benoit Capital Partners LLC Current
Owner
2016 – Present
ML
Maravai LifeSciences
EVP, Advisor
2023 – 2026
AL
Alphazyme LLC
Chief Executive Officer
2018 – 2023
EC
Enzymatics, A QIAGEN Company
VP, Head of Reagents (2014 – 2016)
Senior Vice President, Reagents (2006 – 2014)
2006 – 2016
NB
New England Biolabs
Product Manager/DNA Polymerases
1995 – 2006
Key Colleagues at Startups
The people Christopher Benoit works with at each company, as listed on that company's latest Form D.
Canal Biosciences, Inc. · Form D, Apr 13, 2026
Yu Zheng
Founder & Co-CEO, director
TwinStrand Biosciences, Inc. · Form D, Aug 27, 2018
SD
Steve Dow
Director
JS
Jesse Salk
Executive officer, director and promoter
LL
Lawrence Loeb
Director and promoter